452 related articles for article (PubMed ID: 2668324)
21. Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats.
Bryer-Ash M; Cheung A; Pederson RA
Regul Pept; 1994 May; 51(2):101-9. PubMed ID: 8059006
[TBL] [Abstract][Full Text] [Related]
22. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?
Sarson DL; Wood SM; Kansal PC; Bloom SR
Diabetes; 1984 Apr; 33(4):389-93. PubMed ID: 6368294
[TBL] [Abstract][Full Text] [Related]
23. A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.
Jones IR; Owens DR; Vora J; Luzio SD; Hayes TM
Diabetes Res Clin Pract; 1989 Nov; 7(4):263-9. PubMed ID: 2693029
[TBL] [Abstract][Full Text] [Related]
24. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
25. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs.
Pierluissi J; de Pierluissi R; de Martínez A
Acta Cient Venez; 2002; 53(1):29-35. PubMed ID: 12216497
[TBL] [Abstract][Full Text] [Related]
27. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
28. The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man.
Sarson DL; Wood SM; Holder D; Bloom SR
Diabetologia; 1982 Jan; 22(1):33-6. PubMed ID: 7037506
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects.
Meier JJ; Gallwitz B; Kask B; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetes; 2004 Dec; 53 Suppl 3():S220-4. PubMed ID: 15561915
[TBL] [Abstract][Full Text] [Related]
30. The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.
Meneilly GS; Bryer-Ash M; Elahi D
Diabetes Care; 1993 Jan; 16(1):110-4. PubMed ID: 8422763
[TBL] [Abstract][Full Text] [Related]
31. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
[TBL] [Abstract][Full Text] [Related]
32. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
Meier JJ; Hücking K; Holst JJ; Deacon CF; Schmiegel WH; Nauck MA
Diabetes; 2001 Nov; 50(11):2497-504. PubMed ID: 11679427
[TBL] [Abstract][Full Text] [Related]
33. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Jones IR; Owens DR; Luzio S; Williams S; Hayes TM
Diabetologia; 1989 Sep; 32(9):668-77. PubMed ID: 2676668
[TBL] [Abstract][Full Text] [Related]
34. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
Højberg PV; Vilsbøll T; Rabøl R; Knop FK; Bache M; Krarup T; Holst JJ; Madsbad S
Diabetologia; 2009 Feb; 52(2):199-207. PubMed ID: 19037628
[TBL] [Abstract][Full Text] [Related]
35. Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance.
Eriksen M; Jensen DH; Tribler S; Holst JJ; Madsbad S; Krarup T
Diabetologia; 2015 May; 58(5):920-8. PubMed ID: 25748606
[TBL] [Abstract][Full Text] [Related]
36. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
Jones IR; Owens DR; Luzio S; Hayes TM
Horm Metab Res; 1989 Jan; 21(1):23-6. PubMed ID: 2647605
[TBL] [Abstract][Full Text] [Related]
37. Modifications of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet.
Morgan LM; Hampton SM; Tredger JA; Cramb R; Marks V
Br J Nutr; 1988 May; 59(3):373-80. PubMed ID: 3293660
[TBL] [Abstract][Full Text] [Related]
38. Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans.
Nissen A; Christensen M; Knop FK; Vilsbøll T; Holst JJ; Hartmann B
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2325-9. PubMed ID: 25144635
[TBL] [Abstract][Full Text] [Related]
39. GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals.
Gasbjerg LS; Helsted MM; Hartmann B; Sparre-Ulrich AH; Veedfald S; Stensen S; Lanng AR; Bergmann NC; Christensen MB; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32077470
[TBL] [Abstract][Full Text] [Related]
40. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]